Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it ...

Harrow entered into an agreement to acquire Melt Pharmaceuticals and plans to submit a new drug application for MELT-300, ...

For many people, the mere thought of sitting in a dental chair can trigger intense anxiety. The sounds of dental tools, the clinical environment, and memories of past experiences can ...

AMSTERDAM — Many urologic procedures can be safely performed with the use of conscious sedation rather than general anesthesia, and both clinicians and their patients say they prefer the lighter touch ...

Do you need some tips for that dental visit. Despite the generous dose of laughing gas your dentist may administer during ...

Ethicon Endo-Surgery, a Johnson & Johnson company, announced that the SEDASYS System, the first computer-assisted personalized sedation system, was granted a CE Mark for the European Union for routine ...

To a certain type of person, the appeal of these procedures is self-evident: Getting a needle jabbed into your skin hurts.

Harrow plans to submit a New Drug Application (“NDA”) to the FDA in 2027, with a potential U.S. commercial launch in 2028.